Comparison of inner ear MRI enhancement in patients with Meniere’s disease after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide

Abstract

PurposeTo compare the enhancement results of three gadolinium contrast agents in the inner ear of patients with Meniere’s disease 4 h after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide. MethodsWe enrolled 60 patients with a definitive diagnosis of unilateral Meniere’s disease and divided them into three groups of 20 patients; each group received a double dose of gadobutrol, gadoterate meglumine, or gadodiamide. The postcontrast signal intensity of the basal cochlear turn was scored quantitatively, and qualitative visual evaluation of the cochlea, vestibule and semi-circular canals was also performed. The results of both evaluations were compared between the three patient groups. ResultsThe cochlear basal turn signal intensity of the gadobutrol group was significantly higher than that of the gadoterate meglumine and gadodiamide groups; however, no significant difference was observed between the gadoterate meglumine and gadodiamide groups. The intensity of visualization of the semi-circular canals was significantly better in the bilateral gadobutrol group than in the gadoterate meglumine and gadodiamide groups; however, there was no significant difference in terms of the intensity of visualization of the semi-circular canals between the gadoterate meglumine and gadodiamide groups. There were no significant differences in the intensity of visualization of the cochlea and vestibule among the three groups. ConclusionsCompared with gadoterate meglumine and gadodiamide, gadobutrol can provide a higher degree of perilymphatic enhancement and better anatomical details of the semi-circular canals in the ears of patients with Meniere’s disease.